ong-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patient
Not Applicable
- Conditions
- onychomycosis
- Registration Number
- JPRN-UMIN000053516
- Lead Sponsor
- Muroran City General Hospital
- Brief Summary
The results suggest that the re-administration of fosravuconazole is safe and as effective as the first administration for elderly patients with recurrent onychomycosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with hepatic impairment (AST or ALT: 2.5 times the upper reference limit or 100 U/L) and patients having been treated with warfarin were excluded from this study.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Patient characteristics: Sex, age, and presence or absence of diabetes/renal failure (on dialysis treatment)/use of immunosuppressive drugs.
- Secondary Outcome Measures
Name Time Method